Brawn Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Un-Audited Financial Results ....

BRAWN BIOTECH LTD. Date: August 5, 2026 The Department of Corporate Services, BSE Limited, 25 Floor, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001 BSE Scrip Code: 530207 Scrip Id: BRAWN Intimation under Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20— 1Boa5rd Meetin Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 this is to inform your good office that the meeting of Board of Directors of the Company is scheduled to be held on Thursday, August 13, 2026 to consider and approve inter alia the Un-audited financial results of the Company for the quarter ended June 30, 2026. As intimated in our letter dated June 25, 2026 for the purpose of closure of Trading Window and as per the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window for the dealing in the securities of the Company shall remain closed till August 15, 2026 and accordingly shall reopen on August 16, 2026. Kindly take the above information on record. Thanking You, Yours faithfully, For and on behalf of Brawn Biotech Limited Priyanka Sharma > Company Secretary & Compliance Officer Membership No. A50385 CIN NO.: L74899DL1985PLC022468 +..for betten life Regd. Office : G-64, Lajpat Nagar-1, First Floor, New Delhi-110024, INDIA Tel.: 011-29815331 Email: solution@brawnbiotech.com Works : Plot No.44, Pace City-1, Sector 37, Near Hero Honda Chowk, Gurugram - 122001, Haryana, INDIA BRAWN BIOTECH LTD. Email: distribution@brawnlabs.in | Website : www.brawngroup.in